The CD40-CD40 ligand system: a potential therapeutic _target in atherosclerosis
- PMID: 11572655
The CD40-CD40 ligand system: a potential therapeutic _target in atherosclerosis
Abstract
Atherosclerosis is a leading cause of cardiovascular disease in the westernized world. This review highlights emerging evidence linking atherosclerosis to the CD40-CD40 ligand (CD154) pathway. Recently, atherosclerosis has been associated with chronic inflammation, linking it to the immune system. This novel viewpoint may serve as an additional _target for therapeutic intervention. CD40 and CD154 are highly expressed in atherosclerotic human plaques. Recent data from preclinical animal models of atherosclerosis show that disruption of the CD40-CD154 pathway can prevent atherosclerotic progression and may reverse established lesions. Blockade of the CD40-CD154 pathway by biologicals or small molecules may prove valuable in the treatment of atherosclerosis.
Similar articles
-
Requirement for CD154 in the progression of atherosclerosis.Nat Med. 1999 Nov;5(11):1313-6. doi: 10.1038/15271. Nat Med. 1999. PMID: 10546000
-
The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.Semin Immunol. 2009 Oct;21(5):308-12. doi: 10.1016/j.smim.2009.06.004. Epub 2009 Jul 17. Semin Immunol. 2009. PMID: 19616449 Review.
-
TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.Arterioscler Thromb Vasc Biol. 2007 May;27(5):1101-7. doi: 10.1161/ATVBAHA.107.140566. Epub 2007 Mar 1. Arterioscler Thromb Vasc Biol. 2007. PMID: 17332487
-
CD40 and its ligand in atherosclerosis.Trends Cardiovasc Med. 2007 May;17(4):118-23. doi: 10.1016/j.tcm.2007.02.004. Trends Cardiovasc Med. 2007. PMID: 17482093 Review.
-
Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.Transplantation. 2008 Dec 15;86(11):1615-21. doi: 10.1097/TP.0b013e31818bbd3a. Transplantation. 2008. PMID: 19077898
Cited by
-
Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?Sci Rep. 2014 Nov 28;4:7239. doi: 10.1038/srep07239. Sci Rep. 2014. PMID: 25430087 Free PMC article.
-
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Mediators Inflamm. 2010;2010:174341. doi: 10.1155/2010/174341. Epub 2010 Jun 28. Mediators Inflamm. 2010. PMID: 20652043 Free PMC article. Review.
-
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.Invest Ophthalmol Vis Sci. 2009 May;50(5):2262-8. doi: 10.1167/iovs.08-2328. Epub 2008 Dec 30. Invest Ophthalmol Vis Sci. 2009. PMID: 19117935 Free PMC article.
-
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.Blood. 2007 May 1;109(9):3839-48. doi: 10.1182/blood-2006-07-037994. Epub 2007 Jan 3. Blood. 2007. PMID: 17202317 Free PMC article.
-
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.Blood. 2008 Apr 1;111(7):3553-61. doi: 10.1182/blood-2007-05-088161. Epub 2008 Jan 7. Blood. 2008. PMID: 18180380 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials